Literature DB >> 12067578

Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity.

C Cavin1, D Holzhaeuser, G Scharf, A Constable, W W Huber, B Schilter.   

Abstract

Epidemiological studies have found an inverse association between coffee consumption and the risk of certain types of cancers such as colorectal cancers. Animal data support such a chemopreventive effect of coffee. Substantial research has been devoted to the identification of coffee components that may be responsible for these beneficial effects. In animal models and cell culture systems, the coffee diterpenes cafestol and kahweol (C+K) were shown to produce a broad range of biochemical effects resulting in a reduction of the genotoxicity of several carcinogens including 7,12-dimethylbenz[a]anthracene (DMBA), aflatoxin B(1) (AFB(1)), benzo[a]pyrene (B[a]P) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Different mechanisms appear to be involved in these chemoprotective effects: an induction of conjugating enzymes (e.g. glutathione S-transferases, glucuronosyl S-transferases), an increased expression of proteins involved in cellular antioxidant defense (e.g. gamma-glutamyl cysteine synthetase and heme oxygenase-1) and an inhibition of the expression and/or activity of cytochromes P450 involved in carcinogen activation (e.g. CYP2C11, CYP3A2). In animal models, the C+K-mediated induction of conjugating and antioxidant enzymes has been observed in hepatic, intestinal and kidney tissues. In the small intestine, these inductions were shown to be mediated by Nrf2-dependent transcriptional activation. In vitro investigations obtained in cell cultures of human origin indicate that the effects and mechanisms observed in animal test systems with C+K are likely to be of relevance for humans. In human liver epithelial cell lines transfected to express AFB(1)-activating P450s, C+K treatment resulted in a reduction of AFB(1)-DNA binding. This protection was correlated with an induction of GST-mu, an enzyme known to be involved in AFB(1) detoxification. In addition, C+K was found to inhibit P450 2B6, one of the human enzymes responsible for AFB(1) activation. Altogether, the data on the biological effects of C+K provide a plausible hypothesis to explain some of the anticarcinogenic effects of coffee observed in human epidemiological studies and in animal experiments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067578     DOI: 10.1016/s0278-6915(02)00029-7

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  87 in total

1.  Association between coffee consumption and the risk of oral cancer: a meta-analysis of observational studies.

Authors:  Ying Zhang; Xi Wang; Dan Cui
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP cohort.

Authors:  Xiaomei Ma; Yikyung Park; Susan T Mayne; Rong Wang; Rashmi Sinha; Albert R Hollenbeck; Arthur Schatzkin; Amanda J Cross
Journal:  Am J Epidemiol       Date:  2009-12-30       Impact factor: 4.897

3.  Influence of coffee brew in metabolic syndrome and type 2 diabetes.

Authors:  Sheila Andrade Abrahão; Rosemary Gualberto Fonseca Alvarenga Pereira; Raimundo Vicente de Sousa; Adriene Ribeiro Lima; Gabriela Previatti Crema; Bianca Sacramento Barros
Journal:  Plant Foods Hum Nutr       Date:  2013-06       Impact factor: 3.921

4.  Coffee consumption and risk of lung cancer: the ICARE study.

Authors:  Harinakshi Sanikini; Loredana Radoï; Gwenn Menvielle; Florence Guida; Francesca Mattei; Sylvie Cénée; Diane Cyr; Marie Sanchez; Michel Velten; Matthieu Carton; Annie Schmaus; Danièle Luce; Isabelle Stücker
Journal:  Eur J Epidemiol       Date:  2014-12-13       Impact factor: 8.082

Review 5.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

6.  Chemoprevention against hepatocellular carcinoma.

Authors:  Jun-Ichi Okano; Yuki Fujise; Ryo Abe; Ryu Imamoto; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2011-06-04

Review 7.  TRAIL-mediated signaling in prostate, bladder and renal cancer.

Authors:  Christina Voelkel-Johnson
Journal:  Nat Rev Urol       Date:  2011-06-14       Impact factor: 14.432

Review 8.  Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  A J Carman; P A Dacks; R F Lane; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

9.  Cafestol to Tricalysiolide B and Oxidized Analogues: Biosynthetic and Derivatization Studies Using Non-heme Iron Catalyst Fe(PDP).

Authors:  Marinus A Bigi; Peng Liu; Lufeng Zou; K N Houk; M Christina White
Journal:  Synlett       Date:  2012-12-01       Impact factor: 2.454

10.  Coffee Consumption and the Risk of Colorectal Cancer.

Authors:  Stephanie L Schmit; Hedy S Rennert; Gad Rennert; Stephen B Gruber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.